Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Strengthens Board with the Appointment of Marlou Janssen-Counotte as Non-Executive Director

Marlou brings extensive international commercial experience

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the appointment of Louise Marie ("Marlou") Janssen-Counotte as a Non-executive Director of the Company, with effect from 21 June 2023.

Marlou, a Dutch national, brings a wealth of experience gained in internationally recognised medical technology companies including Philips, Biotronik, St Jude Medical and Medtronic, in which she has held senior commercial leadership roles.  Marlou has extensive international experience and has lived and worked in the USA.  She is currently also a non-executive director of Acarix AB (a Stockholm Nasdaq First North Premier Growth Market listed company).

Mark Abrahams, Chairman of Inspiration Healthcare said: "I am delighted to welcome Marlou to our Board, her extensive international experience and commercial insights as a health tech leader will be beneficial to the Company as we continue to deliver our growth strategy and strengthen our position as a leading specialist innovative medical technology company focused on neonatal intensive care."  

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Louise Marie Janssen-Counotte  (aged 58 years) holds/has held the following directorships/partnerships in the last five years:

Marlou Janssen-Counotte holds no ordinary shares in the Company.

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com